$IVST check out the news today: March 28, 2018 (GLOBE

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
243
$IVST check out the news today: March 28, 2018 (GLOBE NEWSWIRE) -- Innovest Global, Inc. (OTC PINK:IVST) has engaged NMS Inc., to audit its 2016 and 2017 financial results to PCAOB standard. Innovest’s acquisition pipeline now features fourteen companies.

Innovest continued to advance its business plan throughout this month. The company has engaged NMS Inc. to audit its 2016 and 2017 financial results. Management feels having two years of audited financial statements to PCAOB standard is a component necessary for its uplisting strategy. NMS is a Cleveland based, PCAOB compliant Certified Public Accountant firm with 40 employees and a 30-year track record.

The company has integrated three acquisitions in the first quarter, and is now operating with baseline quarterly revenue beginning second quarter 2018, of $800,000 in its Commercial & Industrial Division. The acquisition of H.P. Technologies last week, is the most recent. The Biotechnology & Health Sciences Division will launch upon its first completed transaction, expected this spring. The current pipeline of fourteen companies includes seven in the Commercial & Industrial Division, three in Biotechnology & Health Sciences. The others would mark entry into subsequent divisions. Eleven of the fourteen companies each generate greater annual revenue than Innovests current base, showing the business plan advancing to incrementally larger transactions. The company sees additions to, and subtractions from, the pipeline list regularly.

“We have a proprietary five-phase acquisition pipeline model,” said Dan Martin, CEO of Innovest Global, Inc. “To make the list, the first phase is that we’ve spoken to the decision maker, and that person is seriously interested in exploring the terms of a possible transaction.” At that point the company gets extremely focused advancing each opportunity through the pipeline. Mr. Martin continued, “What can’t be lost is that these are incredibly important decisions for the owners. In some cases they have spent their entire lives building a business. And I’m incredibly honored that they consider us, as a successor to help take it to the next level. We operate on their timeline, respectful of their particular considerations, and seek longstanding relationships as a priority.”

More about NMS Inc.

NMS is a full service accounting, tax and wealth management firm providing essential and unique solutions for individuals and businesses. Their goal is to keep clients fully compliant while also helping to ensure they reach financial success. They have been in business for over 30 years and have helped more than 10,000 clients in Chardon, Mentor, Twinsburg, Middlefield and the surrounding areas. Their staff of over 40, include CPA’s and professionals who deliver superior service and offer personalized solutions to their clients needs.

It has been a busy month at Innovest, for both the Commercial & Industrial Division, and the forthcoming Biotechnology & Health Sciences Division. Look for much more information to come soon. As noted consistently, the company will increasingly use Twitter, which can be accessed both on Twitter @innovestglobal and on the front page of our website www.innovestglobal.com, for important company updates. This includes information that may be material, so please follow us and visit our website regularly! For more information on Innovest contact info@innovestglobal.com, or call Innovest investor Relations Matt Rego at 216.815.1122.

http://www.innovestglobal.com

https://finance.yahoo.com/news/innovest-globa...00729.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles